The Diagnostic and Prognostic Value of Two Quantitative Clinical Tests in Patients With Lumbar Disc Herniation
1 other identifier
interventional
102
1 country
1
Brief Summary
This study will investigate whether two clinical tests can be used to diagnose and predict the outcome in patients with lumbar disc herniation undergoing surgery and non-surgery treatment. The two quantitative clinical tests include: electromyographic measurements using Paraspinal Mapping and pain responses using Quantitative Sensory Pain Testing.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable pain
Started Oct 2018
Typical duration for not_applicable pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2018
CompletedFirst Submitted
Initial submission to the registry
October 26, 2018
CompletedFirst Posted
Study publicly available on registry
February 6, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2021
CompletedJuly 8, 2025
July 1, 2025
2.3 years
October 26, 2018
July 2, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The diagnostic value of Paraspinal Mapping and Quantitative Sensory Pain Testing
8 week follow-up
Study Arms (1)
Patients with lumbar disc herniation
EXPERIMENTALInterventions
Participants will be tested at baseline.
Eligibility Criteria
You may qualify if:
- Clinical and radiologically diagnosed lumbar disc herniation.
- Low back pain with pain below the knee or anterior thigh pain in one or both legs.
- Dermatomal leg pain.
- Average pain intensity of 3 or more on a Numerical Rating Scale (0-10 NRS).
You may not qualify if:
- History of previous lumbar spine surgery.
- Surgery in general in the past 4 months.
- Current use of anticoagulants.
- Diagnoses which could confound with the diagnosis e.g. lumbar spinal stenosis, local muscle trauma, cancer metastases, fibromyalgia, neuropathy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Center for Rheumatology and Spine Diseases, Frederiksberg Hospital.
Frederiksberg, 2000, Denmark
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Johanne B Filtenborg, M.Sc.
Spine Centre Southern Denmark
- STUDY DIRECTOR
Berit Schiøttz-Christensen, MD
Spine Centre Southern Denmark
- STUDY CHAIR
Søren O'Neill, DC
Spine Centre Southern Denmark
- STUDY CHAIR
Kirstine Amris, MD
The Parker Institute, Frederiksberg Hospital
- STUDY CHAIR
Gilles Fournier, MD, DC
Center for Rheumatology and Spine Diseases, Frederiksberg Hospital
- STUDY CHAIR
Andrew J Haig, MD
University of Michigan
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 26, 2018
First Posted
February 6, 2019
Study Start
October 1, 2018
Primary Completion
January 1, 2021
Study Completion
January 1, 2021
Last Updated
July 8, 2025
Record last verified: 2025-07